EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Decoding Microbiome’s Role in Prostate Cancer Progression and Treatment Response

Minas Sakellakis, Panagiota Resta, Evangelia Papagianni, Kassandra A Procter iD, Irene Belouka, Katerina Gioti iD, Fragkiski Anthouli-Anagnostopoulou iD, Dimitrios Chaniotis iD, Apostolos Beloukas iD

Diseases · 05.09.2025 · 13 (9) · 294

DOI: 10.3390/diseases13090294 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 05.09.2025. Verfasst von Minas Sakellakis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jacobi North Central Bronx Hospital, The Albert Einstein College of Medicine, Bronx, NY 10461, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the most common genitourinary malignancy in men, with a multifactorial etiology influenced by genetic, environmental, and microbial determinants. Although the prostate was traditionally considered sterile, advances in microbiome research have challenged this view, revealing potential links between microbial communities and PCa development, progression, and treatment response. This review synthesizes evidence on the gut, urinary, seminal fluid, and prostatic microbiomes, highlighting their potential contributions to PCa pathogenesis and therapeutic outcomes. Key studies utilizing next-generation sequencing (NGS), whole-genome sequencing (WGS), PCR, and metagenomic analyses have identified specific bacterial and fungal taxa associated with Pca; however, findings remain inconsistent across methodologies and cohorts. Microorganisms such as Propionibacterium acnes and Pseudomonas spp. may modulate inflammation, immune responses, and resistance to androgen-deprivation therapy. Further research is required to determine whether microbial signatures can serve as reliable biomarkers for early detection, prognosis, or novel therapeutic strategies in PCa management.

Schlagwörter

Stichwörter der Autor:innen

gut microbiomemicrobial biomarkermicrobiotanext-generation sequencingprostate cancer

Autor:innen und Institutionen

  • Department of Medicine, Jacobi North Central Bronx Hospital, The Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Department of Biomedical Sciences, School of Health Sciences, University of West Attica, Egaleo, 12243 Athens, Greece.

ORCID-Profile: Kassandra A Procter, Katerina Gioti, Fragkiski Anthouli-Anagnostopoulou, Dimitrios Chaniotis, Apostolos Beloukas

Zitieren

APA

Sakellakis, M., Resta, P., Papagianni, E., Procter, K. A., Belouka, I., Gioti, K., Anthouli-Anagnostopoulou, F., Chaniotis, D., & Beloukas, A. (2025). Decoding Microbiome’s Role in Prostate Cancer Progression and Treatment Response. Diseases, 13(9), 294. https://doi.org/10.3390/diseases13090294

Vancouver

Sakellakis M, Resta P, Papagianni E, Procter KA, Belouka I, Gioti K, et al. Decoding Microbiome’s Role in Prostate Cancer Progression and Treatment Response. Diseases. 2025;13(9):294. doi:10.3390/diseases13090294

BibTeX
@article{Sakellakis2025,
  author = {Sakellakis, Minas and Resta, Panagiota and Papagianni, Evangelia and Procter, Kassandra A and Belouka, Irene and Gioti, Katerina and Anthouli-Anagnostopoulou, Fragkiski and Chaniotis, Dimitrios and Beloukas, Apostolos},
  title = {Decoding Microbiome’s Role in Prostate Cancer Progression and Treatment Response},
  journal = {Diseases},
  year = {2025},
  volume = {13},
  number = {9},
  pages = {294},
  doi = {10.3390/diseases13090294}
}
Kostenlos starten →